Enliang Li

1.2k total citations
52 papers, 801 citations indexed

About

Enliang Li is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Enliang Li has authored 52 papers receiving a total of 801 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 12 papers in Surgery and 12 papers in Oncology. Recurrent topics in Enliang Li's work include Pancreatic and Hepatic Oncology Research (8 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers) and Gallbladder and Bile Duct Disorders (7 papers). Enliang Li is often cited by papers focused on Pancreatic and Hepatic Oncology Research (8 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers) and Gallbladder and Bile Duct Disorders (7 papers). Enliang Li collaborates with scholars based in China, Australia and United States. Enliang Li's co-authors include Tingbo Liang, Xing Huang, Gang Zhang, Xiaozhen Zhang, Tianyu Tang, Xun Wang, Xueli Bai, Yingmin Wang, Linquan Wu and Wenjun Liao and has published in prestigious journals such as Nature Communications, Scientific Reports and ACS Applied Materials & Interfaces.

In The Last Decade

Enliang Li

47 papers receiving 786 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Enliang Li China 14 353 275 187 179 153 52 801
Xuchao Zhang China 16 432 1.2× 373 1.4× 134 0.7× 297 1.7× 190 1.2× 44 923
Ning Lyu China 19 352 1.0× 503 1.8× 180 1.0× 459 2.6× 284 1.9× 70 1.4k
Norifumi Hattori Japan 16 306 0.9× 275 1.0× 64 0.3× 103 0.6× 217 1.4× 91 889
Kuniaki Sato Japan 17 236 0.7× 537 2.0× 82 0.4× 339 1.9× 99 0.6× 66 852
Radovan Jiřík Czechia 11 111 0.3× 268 1.0× 41 0.2× 248 1.4× 68 0.4× 53 934
Naining Wang Sweden 16 200 0.6× 258 0.9× 32 0.2× 128 0.7× 214 1.4× 46 751
Guoqiang Su China 14 263 0.7× 549 2.0× 78 0.4× 296 1.7× 148 1.0× 57 991
A Yamaguchi Japan 17 610 1.7× 355 1.3× 60 0.3× 128 0.7× 388 2.5× 97 1.3k
Kamlesh K. Yadav United States 14 156 0.4× 412 1.5× 42 0.2× 305 1.7× 322 2.1× 30 895

Countries citing papers authored by Enliang Li

Since Specialization
Citations

This map shows the geographic impact of Enliang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Enliang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Enliang Li more than expected).

Fields of papers citing papers by Enliang Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Enliang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Enliang Li. The network helps show where Enliang Li may publish in the future.

Co-authorship network of co-authors of Enliang Li

This figure shows the co-authorship network connecting the top 25 collaborators of Enliang Li. A scholar is included among the top collaborators of Enliang Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Enliang Li. Enliang Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Cheng‐Peng, et al.. (2025). New insights into Gremlin-1: A tumour microenvironment landscape re-engineer and potential therapeutic target. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1872(5). 119962–119962. 1 indexed citations
2.
He, Liang, Enliang Li, Xiaoyue Duan, et al.. (2025). Temperature Sensitivity of Vertical Ga₂O₃ Junction Barrier Schottky Diode Using the p-NiO/n-Ga₂O₃ Heterojunction. IEEE Sensors Journal. 25(6). 9401–9407.
3.
Li, Enliang, Zhi-Ming Shao, Jiayan Mao, et al.. (2025). METTL3-mediated TUG1 regulation of miR-9 in doxorubicin resistance in HCC. Life Sciences. 378. 123832–123832.
4.
Li, Enliang, et al.. (2024). Effective Nonstoichiometric Strategy Combined Post-annealing Process for Boosting Thermoelectric Properties in n-Type PbTe. ACS Applied Materials & Interfaces. 16(15). 19048–19056. 4 indexed citations
5.
Huang, Le, et al.. (2024). Regulation of CD73 on NAD metabolism: Unravelling the interplay between tumour immunity and tumour metabolism. Cell Communication and Signaling. 22(1). 387–387. 6 indexed citations
6.
Liu, Weiwei, et al.. (2023). LncTUG1 promotes hepatocellular carcinoma immune evasion via upregulating PD-L1 expression. Scientific Reports. 13(1). 16998–16998. 9 indexed citations
7.
Huang, Zhihao, Jiakun Wang, Min Li, et al.. (2023). Pancreatic adenosquamous carcinoma: A population level analysis of epidemiological trends and prognosis. Cancer Medicine. 12(8). 9926–9936. 11 indexed citations
8.
Li, Min, Jiakun Wang, Cong Wang, et al.. (2023). Validation of the Prognostic Role for Surgical Treatment in Stage II Intrahepatic Cholangiocarcinoma: A SEER Population-Based Study. Journal of Clinical Medicine. 12(2). 675–675. 1 indexed citations
9.
Tang, Zengwei, Yuan Yang, Wen Chen, Enliang Li, & Tingbo Liang. (2022). Demethylation at enhancer upregulates MCM2 and NUP37 expression predicting poor survival in hepatocellular carcinoma patients. Journal of Translational Medicine. 20(1). 49–49. 11 indexed citations
10.
Xiong, Jianghui, Ping Hou, Jiakun Wang, et al.. (2022). Comprehensive analysis of the effects of KIF2C on prognosis, biological functions and immune infiltration in PAAD. Tissue and Cell. 78. 101900–101900. 3 indexed citations
11.
Yang, Jun, Enliang Li, Yuting Liao, et al.. (2022). Metabolic signatures of hepatolithiasis using ultra-high performance liquid chromatography-tandem mass spectrometry. Metabolomics. 18(9). 69–69. 4 indexed citations
12.
Yang, H. J., et al.. (2022). Robotic versus open extended cholecystectomy for T1a–T3 gallbladder cancer: A matched comparison. Frontiers in Surgery. 9. 1039828–1039828. 4 indexed citations
13.
Liu, Weiwei, Qian Feng, Wenjun Liao, Enliang Li, & Linquan Wu. (2021). TUG1 promotes the expression of IFITM3 in hepatocellular carcinoma by competitively binding to miR-29a. Journal of Cancer. 12(22). 6905–6920. 10 indexed citations
14.
Huang, Xing, Enliang Li, Hang Shen, et al.. (2020). Targeting the HGF/MET Axis in Cancer Therapy: Challenges in Resistance and Opportunities for Improvement. Frontiers in Cell and Developmental Biology. 8. 152–152. 56 indexed citations
15.
Li, Enliang, Weiwei Liu, Qingping Yang, et al.. (2020). <p>Circular RNA MYLK Promotes Hepatocellular Carcinoma Progression Through the miR29a/KMT5C Signaling Pathway</p>. OncoTargets and Therapy. Volume 13. 8615–8627. 16 indexed citations
16.
Wang, Jiakun, Enliang Li, Hao Yang, et al.. (2019). Combined hepatocellular-cholangiocarcinoma: a population level analysis of incidence and mortality trends. World Journal of Surgical Oncology. 17(1). 43–43. 30 indexed citations
17.
18.
Liang, Bo, Hongliang Liu, Xiangbao Yin, et al.. (2017). Overexpression of non-SMC condensin I complex subunit G serves as a promising prognostic marker and therapeutic target for hepatocellular carcinoma. International Journal of Molecular Medicine. 40(3). 731–738. 47 indexed citations
19.
Li, Enliang, et al.. (2017). Rare anatomic variation of the right hepatic artery and accessory right hepatic artery supplying hepatocellular carcinoma. Medicine. 96(39). e8144–e8144. 11 indexed citations
20.
Li, Enliang, et al.. (2017). Simple resection of the lesion bile duct branch for treatment of regional hepatic bile duct stones. Medicine. 96(27). e7414–e7414. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xuchao Zhang Breakdown of academic impact, for papers by Ning Lyu Breakdown of academic impact, for papers by Norifumi Hattori Breakdown of academic impact, for papers by Kuniaki Sato Breakdown of academic impact, for papers by Radovan Jiřík Breakdown of academic impact, for papers by Naining Wang Breakdown of academic impact, for papers by Guoqiang Su Breakdown of academic impact, for papers by A Yamaguchi Breakdown of academic impact, for papers by Kamlesh K. Yadav
Rankless by CCL
2026